A Double-Blind, Placebo-Controlled Crossover Study of Repeat Rivastigmine (Exelon®) Administration in Young Healthy Male Volunteers - No Study Results Posted

A Double-Blind, Placebo-Controlled Crossover Study of Repeat Rivastigmine (Exelon®) Administration in Young Healthy Male Volunteers (RIVA-1)

This study is not yet open for participant recruitment.

Study NCT00624663 Information provided by Tel-Aviv Sourasky Medical Center

First Received: October 30, 2007 Last Updated: February 15, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is not yet open for participant recruitment.
Estimated Study Completion Date:	September 2008
Estimated Primary Completion Date:	June 2008 (Final data collection date for primary outcome measure)